期刊
RSC ADVANCES
卷 7, 期 10, 页码 6046-6058出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c6ra26737h
关键词
-
资金
- Key Program of Natural Science Foundation of State [81302905, 81373930, 81430093, 81673586]
- National Key Subject of Drug Innovation [2015ZX09101043-005, 2015ZX09101043-011]
- TCM State Administration Subject of Public Welfare [2015468004]
- Natural Science Foundation of Heilongjiang Province of China [H2015038]
- University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province [UNPYSCT-2015118]
Alzheimer's disease is a progressive and irreversible neurodegenerative disease, associated with a decreased cognitive function and severe behavioral abnormalities. Due to its complex pathophysiological characteristics, complicated interactions with a large number of genes and proteins, there is still no effective drug treatment of the disease. Amyloid cascade aggregation of senile plaques and hyperphosphorylation of Tau protein to form neurofibrillary tangles are the main pathological features of Alzheimer's disease, other mechanisms, such as oxidative stress, lack of central cholinergic neurotransmitters, inflammatory reaction and toxic metal ions have also been involved. The purpose of this review is to briefly introduce the progress of the development of the therapeutic agents based on their main mechanisms of action.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据